Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Citi
Chinese Patent Office
Boehringer Ingelheim
Healthtrust
Merck
Moodys
McKinsey

Generated: July 18, 2018

DrugPatentWatch Database Preview

SEROSTIM Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Serostim, and when can generic versions of Serostim launch?

Serostim is a drug marketed by Emd Serono and is included in one NDA.

The generic ingredient in SEROSTIM is somatropin recombinant. There are four drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the somatropin recombinant profile page.
Summary for SEROSTIM
Drug patent expirations by year for SEROSTIM

US Patents and Regulatory Information for SEROSTIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-003 Jul 25, 1997 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-004 Sep 6, 2001 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-002 Aug 23, 1996 BX RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-001 Aug 23, 1996 BX RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for SEROSTIM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-003 Jul 25, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-001 Aug 23, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-004 Sep 6, 2001 ➤ Try a Free Trial ➤ Try a Free Trial
Emd Serono SEROSTIM somatropin recombinant INJECTABLE;INJECTION 020604-002 Aug 23, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Johnson and Johnson
Covington
Argus Health
Baxter
Farmers Insurance
Chinese Patent Office
Deloitte
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.